BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7892123)

  • 21. Polymorphism in the nuclear excision repair gene ERCC2/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma.
    Lovatt T; Alldersea J; Lear JT; Hoban PR; Ramachandran S; Fryer AA; Smith AG; Strange RC
    Hum Mutat; 2005 Apr; 25(4):353-9. PubMed ID: 15776433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
    van Rossum MM; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof PC; Kiemeney LA; Hoogerbrugge N
    Arch Dermatol Res; 2009 Apr; 301(4):295-9. PubMed ID: 18985366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the Molecular Genetics of Basal Cell Carcinoma.
    Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
    Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
    Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sonic hedgehog signaling in basal cell carcinomas.
    Daya-Grosjean L; Couvé-Privat S
    Cancer Lett; 2005 Jul; 225(2):181-92. PubMed ID: 15978322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat shock protein HSP 27 is expressed in all types of basal cell carcinoma in low and high risk UV exposure groups.
    Bayerl C; Dorfner B; Rzany B; Fuhrmann E; Coelho CC; Jung EG
    Eur J Dermatol; 1999 Jun; 9(4):281-4. PubMed ID: 10356405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
    Chen B; Campos EI; Crawford R; Martinka M; Li G
    Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of CD44 isoforms in basal cell carcinomas.
    Baum HP; Schmid T; Schock G; Reichrath J
    Br J Dermatol; 1996 Mar; 134(3):465-8. PubMed ID: 8731670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
    Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
    Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics and risk factors for basal cell carcinoma.
    Madan V; Hoban P; Strange RC; Fryer AA; Lear JT
    Br J Dermatol; 2006 May; 154 Suppl 1():5-7. PubMed ID: 16712709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in clinical presentation of basal cell carcinoma.
    Buljan M; Bulat V; Situm M; Mihić LL; Stanić-Duktaj S
    Acta Clin Croat; 2008 Mar; 47(1):25-30. PubMed ID: 18714644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and Management of Hereditary Basal Cell Skin Cancer.
    Shanley S; McCormack C
    Recent Results Cancer Res; 2016; 205():191-212. PubMed ID: 27075355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding the Genetic Profile of BCC.
    Cancer Discov; 2016 May; 6(5):OF2. PubMed ID: 27006369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basal cell carcinoma: a paradigm for targeted therapies.
    Dreier J; Felderer L; Barysch M; Rozati S; Dummer R
    Expert Opin Pharmacother; 2013 Jul; 14(10):1307-18. PubMed ID: 23656611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The glutathione-S-transferase P1 polymorphisms correlates with changes in expression of TP53 tumor suppressor in cutaneous basal cell carcinoma.
    Gorji H; Shahbazi N; Habibollahi P; Tavangar SM; Firooz A; Ghahremani MH
    J Dermatol Sci; 2009 Dec; 56(3):208-10. PubMed ID: 19800766
    [No Abstract]   [Full Text] [Related]  

  • 37. Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer.
    Ganti AK; Kessinger A
    Cancer Treat Rev; 2011 Oct; 37(6):440-3. PubMed ID: 21216106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma.
    Lupu M; Caruntu C; Ghita MA; Voiculescu V; Voiculescu S; Rosca AE; Caruntu A; Moraru L; Popa IM; Calenic B; Greabu M; Costea DE
    Dis Markers; 2016; 2016():9831237. PubMed ID: 27578920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes.
    Correia de Sá TR; Silva R; Lopes JM
    Future Oncol; 2015 Nov; 11(22):3011-21. PubMed ID: 26449153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal-cell carcinoma.
    Rubin AI; Chen EH; Ratner D
    N Engl J Med; 2005 Nov; 353(21):2262-9. PubMed ID: 16306523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.